How long is an investigator required to keep consent documents IRB correspondence and research records?A. Until the study is closedB. Until data analysis is completeC. For a minimum of three years after completion of the studyD. As long as the investigator is at that institution

Quesiton : How long is an investigator required to keep consent documents IRB correspondence and research records?A. Until the study is closedB. Until data analysis is completeC. For a minimum of three years after completion of the studyD. As long as the investigator is at that institution

Answer: C. For a minimum of three years after completion of the study

Most relevent text from all around web: How long is an investigator required to keep consent documents IRB correspondence and research records?A. Until the study is closedB. Until data analysis is completeC. For a minimum of three years after completion of the studyD. As long as the investigator is at that institution How long is an investigator required to keep consent documents IRB correspondence and research records? A . Until the study is closed B . Until data analysis is complete C . For a minimum of three years after completion of the study D . As long as the investigator is at that institution How long is an investigator required to keep consent documents IRB correspondence and research records ? For a minimum of three years after completion of the study . According to federal regulations which of the following best describes when expedited review of a new proposed study may be used by the IRB ? ... (the research data have been ... Investigator Requirements for Retaining Research Data . Regulations require each investigator to retain research data not only while the research is being conducted but also after the research is completed. How long do you have to keep the records after the completion of the research ? Wed Jul 12 2017 · How long is an investigator required to keep consent documents irb correspondence and research records ? Get the answers you need now! Report the adverse drug experience in a timely manner in ...